Identification of molecular markers and exploration of the oncogenic role of exomeres in hepatocellular carcinoma.
1/5 보강
Extracellular vesicles and particles (EVPs) serve as functional mediators delivering their cargoes to specific destinations.
APA
Yeung CLS, Lai CJ, et al. (2025). Identification of molecular markers and exploration of the oncogenic role of exomeres in hepatocellular carcinoma.. Cell reports, 44(11), 116460. https://doi.org/10.1016/j.celrep.2025.116460
MLA
Yeung CLS, et al.. "Identification of molecular markers and exploration of the oncogenic role of exomeres in hepatocellular carcinoma.." Cell reports, vol. 44, no. 11, 2025, pp. 116460.
PMID
41201090 ↗
Abstract 한글 요약
Extracellular vesicles and particles (EVPs) serve as functional mediators delivering their cargoes to specific destinations. Exomeres (EMs) represent a newly discovered subset of nanoparticles, with limited understanding of their biophysical characteristics and functionalities. Here, we isolated and studied EMs from different normal and cancer cell lines. Proteomic analysis reveals distinctive features of EMs compared to small extracellular vesicles (sEVs) and identifies galactosamine (N-acetyl)-6-sulfatase (GALNS) and mannosidase alpha class 2B member 1 (MAN2B1) to be expressed in EMs, indicating their potential as specific EM molecular markers. Subsequent investigations into tumor-derived EMs demonstrate their oncogenic properties to support cancer growth and metastasis. Furthermore, analysis of murine hepatocellular carcinoma-derived EM reveals their ability to induce cell cycle progression and metabolic alterations. Collectively, our data highlight the distinct nature of EMs as a nanoparticle subpopulation different from sEVs, with cancer-derived EMs significantly contributing to tumor growth and dissemination.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Key Considerations for Targeting in Pancreatic Cancer: Potential Impact on the Treatment Paradigm.
- Raman Spectroscopic Signatures of Hepatic Carcinoma: Progress and Future Prospect.
- The role of disulfidptosis-driven tumor microenvironment remodeling in pancreatic cancer progression.
- Effective use of PROs for survival prediction: Transformer-based modelling in NSCLC patients.
- Combining network pharmacology and experimental validation to study the action and mechanism of brusatol against lung adenocarcinoma.
- Acquired L858R mutation following -TKI resistance in lung adenocarcinoma: a case report.